Bicycle Therapeutics plc Finance Lease, Weighted Average Discount Rate, Percent
Bicycle Therapeutics plc (BCYC) had Finance Lease, Weighted Average Discount Rate, Percent of 9.50% as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2026-07-30
- 2026-06-30: Finance Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2026-03-31: Finance Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2025-12-31: Finance Lease, Weighted Average Discount Rate, Percent 9.50%.
- 2025-09-30: Finance Lease, Weighted Average Discount Rate, Percent 9.50%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2026-06-30 | 9.50% 10-Q · filed 2026-07-30 |
| 2026-03-31 | 9.50% 10-Q · filed 2026-04-30 |
| 2025-12-31 | 9.50% 10-K · filed 2026-03-17 |
| 2025-09-30 | 9.50% 10-Q · filed 2025-10-30 |
| 2025-06-30 | 9.50% 10-Q · filed 2026-07-30 |
| 2025-03-31 | 9.50% 10-Q · filed 2026-04-30 |
| 2024-12-31 | 9.50% 10-K · filed 2026-03-17 |
| 2024-09-30 | 9.50% 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |